D S Wilbur - JoVE Visualize

Showing results (21-30 of 41) with videos related to

Pageof 5

Sort By:

Nuclear Medicine and Biology|November 1, 1993

Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2D S Wilbur, R L Vessella, J E Stray, et al.

Nuclear Medicine and Biology|May 1, 1994

Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazoleD S Wilbur, D K Hamlin, J C Livesey, et al.

Bioconjugate Chemistry|November 1, 1991

Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugateM D Hylarides, D S Wilbur, M W Reed, et al.

Bioconjugate Chemistry|July 18, 2000

Biotin reagents for antibody pretargeting. 4. Selection of biotin conjugates for in vivo application based on their dissociation rate from avidin and streptavidinD S Wilbur, M K Chyan, P M Pathare, et al.

Bioconjugate Chemistry|March 1, 1997

Synthesis of cobalamin dimers using isophthalate cross-linking of corrin ring carboxylates and evaluation of their binding to transcobalamin IIP M Pathare, D S Wilbur, D K Hamlin, et al.

Bioconjugate Chemistry|May 20, 1998

Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacityD S Wilbur, D K Hamlin, K R Buhler, et al.

Cancer Research|October 27, 1997

Cobalamin analogues modulate the growth of leukemia cells in vitroG R McLean, P M Pathare, D S Wilbur, et al.

Bioconjugate Chemistry|July 18, 2000

Evaluation of biotin-dye conjugates for use in an HPLC assay to assess relative binding of biotin derivatives with avidin and streptavidinD S Wilbur, P M Pathare, D K Hamlin, et al.

Immunotechnology : an International Journal of Immunological Engineering|December 16, 1998

Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubilityP H Tan, V Chu, J E Stray, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1994

Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boostT A Buchholz, G E Laramore, P Wootton, et al.

Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:

Pageof 5

Nuclear Medicine and Biology|November 1, 1993

Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2D S Wilbur, R L Vessella, J E Stray, et al.

Nuclear Medicine and Biology|May 1, 1994

Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazoleD S Wilbur, D K Hamlin, J C Livesey, et al.

Bioconjugate Chemistry|November 1, 1991

Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugateM D Hylarides, D S Wilbur, M W Reed, et al.

Bioconjugate Chemistry|July 18, 2000

Biotin reagents for antibody pretargeting. 4. Selection of biotin conjugates for in vivo application based on their dissociation rate from avidin and streptavidinD S Wilbur, M K Chyan, P M Pathare, et al.

Bioconjugate Chemistry|March 1, 1997

Synthesis of cobalamin dimers using isophthalate cross-linking of corrin ring carboxylates and evaluation of their binding to transcobalamin IIP M Pathare, D S Wilbur, D K Hamlin, et al.

Bioconjugate Chemistry|May 20, 1998

Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacityD S Wilbur, D K Hamlin, K R Buhler, et al.

Cancer Research|October 27, 1997

Cobalamin analogues modulate the growth of leukemia cells in vitroG R McLean, P M Pathare, D S Wilbur, et al.

Bioconjugate Chemistry|July 18, 2000

Evaluation of biotin-dye conjugates for use in an HPLC assay to assess relative binding of biotin derivatives with avidin and streptavidinD S Wilbur, P M Pathare, D K Hamlin, et al.

Immunotechnology : an International Journal of Immunological Engineering|December 16, 1998

Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubilityP H Tan, V Chu, J E Stray, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1994

Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boostT A Buchholz, G E Laramore, P Wootton, et al.

Pageof 5